Trial record 1 of 3 for:    anal cancer | United States, Rhode Island
Previous Study | Return to List | Next Study

A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer (276)

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2014 by Brown University
Sponsor:
Collaborators:
Rhode Island Hospital
The Miriam Hospital
Montefiore Medical Center
Boston Medical Center
M.D. Anderson Cancer Center
Rutgers Cancer Institute of New Jersey
Ohio State University Comprehensive Cancer Center
Information provided by (Responsible Party):
howard safran, Brown University
ClinicalTrials.gov Identifier:
NCT01671488
First received: August 7, 2012
Last updated: August 29, 2014
Last verified: August 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: May 2018
  Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)